At the protein level, PSMD3 was found to be upregulated in 5/5 (100%) CPTAC cancers, including breast cancer, colon cancer, ovarian cancer, clear cell RCC, and UCEC (Figure 2B). This evidence concerns the gene PSMD3 and ovarian carcinoma.